# ERIBULIN MESYLATE
> **ANDA218281** · Abbreviated New Drug Application (Generic) · Sponsor: JIANGXI KVVIT PHARM · Approved 2024-06-28
## Drug
- **FDA Application Number:** ANDA218281
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ERIBULIN MESYLATE
- **Generic name:** ERIBULIN MESYLATE
- **Active ingredients:** ERIBULIN MESYLATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** JIANGXI KVVIT PHARM
- **Manufacturer:** HIKMA PHARMACEUTICALS USA INC.
- **First approval:** 2024-06-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218281)
---
*MORVS · CC0 1.0*